Proximal-type epithelioid sarcoma of the uterine corpus

Histopathology

Volumn 58, Issue 2, 2011, Pages 321-323

  Venizelos, Ioannis ^a   Anagnostou, Eleftherios ^a   Papathomas, Thomas G ^a   Arsos, Georgios ^b   Mentzel, Thomas ^c  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN S 100; SMOOTH MUSCLE ACTIN; TUBERCULOSTATIC AGENT; VIMENTIN;

ADULT; ANEMIA; BONE MARROW BIOPSY; CASE REPORT; DIAGNOSTIC IMAGING; EPITHELIOID SARCOMA; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; TUBERCULIN TEST; UTERINE CORPUS PROXIMAL EPITHELIOID SARCOMA; UTERUS MYOMA; WEIGHT REDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; SARCOMA; UTERINE NEOPLASMS;

EID: 79951678155     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03738.x     Document Type: Letter

References (13)

1. Guillou L, Wadden C, Coindre JM, Krausz T, Fletcher CD. 'Proximal-type' epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am. J. Surg. Pathol. 1997; 21; 130-146.
2. Fletcher CDM, Unni KK, Mertens F eds. World Healh Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press, 2002.
3. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am. J. Surg. Pathol. 2009; 33; 542-550.
4. Chbani L, Guillou L, Terrier P et al. Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group. Am. J. Clin. Pathol. 2009; 131; 222-227.
5. Kohashi K, Izumi T, Oda Y et al. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum. Pathol. 2009; 40; 349-355.
6. Flucke U, Slootweg PJ, Mentzel T, Pauwels P, Hulsebos TJ. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Hum. Pathol. 2009; 40; 1361-1362.
7. Modena P, Lualdi E, Facchinetti F et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005; 65; 4012-4019.
8. Argenta PA, Thomas S, Chura JC. Proximal-type epithelioid sarcoma vs. malignant rhabdoid tumor of the vulva: a case report, review of the literature, and an argument for consolidation. Gynecol. Oncol. 2007; 107; 130-135.
9. Oda Y, Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol. Int. 2006; 56; 287-295.
10. Izumi T, Oda Y, Hasegawa T et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod. Pathol. 2006; 19; 820-831.
11. Weiss SW, Goldblum JR eds. Enzinger and Weiss's soft tissue tumors. Philadelphia: Mosby, 2007.
12. Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am. J. Surg. Pathol. 2004; 28; 1485-1491.
13. Jeney H, Heller DS, Hameed M, Sama J, Cracchiolo B. Epithelioid sarcoma of the uterine cervix. Gynecol. Oncol. 2003; 89; 536-539.